Re-routing GPR56 signalling using Gα12/13 G protein chimeras
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Re-routing GPR56 signalling using Gα12/13 G protein chimeras. / Faas, Felix; Nørskov, Amalie; Holst, Peter J.; Andersson, Anne Marie; Qvortrup, Katrine; Mathiasen, Signe; Rosenkilde, Mette M.
In: Basic and Clinical Pharmacology and Toxicology, Vol. 133, No. 4, 2023, p. 378-389.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Re-routing GPR56 signalling using Gα12/13 G protein chimeras
AU - Faas, Felix
AU - Nørskov, Amalie
AU - Holst, Peter J.
AU - Andersson, Anne Marie
AU - Qvortrup, Katrine
AU - Mathiasen, Signe
AU - Rosenkilde, Mette M.
N1 - Publisher Copyright: © 2023 The Authors. Basic & Clinical Pharmacology & Toxicology published by John Wiley & Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).
PY - 2023
Y1 - 2023
N2 - Adhesion G protein-coupled receptors (aGPCRs) constitute the second largest subclass of the GPCR superfamily. Although canonical GPCRs are explored pharmacologically as drug targets, no clinically approved drugs target the aGPCR family so far. The aGPCR GPR56/ADGRG1 stands out as an especially promising target, given its direct link to the monogenetic disease bilateral frontoparietal polymicrogyria and implications in cancers. Key to understanding GPCR pharmacology has been mapping out intracellular signalling activity. Detection of GPCR signalling in the Gαs/Gαi/Gαq G protein pathways is feasible with second messenger detection systems. However, in the case of Gα12/13-coupled receptors, like GPR56, signalling detection is more challenging due to the lack of direct second messenger generation. To overcome this challenge, we engineered a Gαq chimera to translate Gα12/13 signalling. We show the ability of the chimeric GαΔ6q12myr and GαΔ6q13myr to translate basal Gα12/13 signalling of GPR56 to a Gαq readout in transcription factor luciferase reporter systems and show that the established peptide ligands (P7 and P19) function to enhance this signal. We further demonstrate the ability to directly influence the generation of second messengers in inositol-3-phosphate assays. In the future, these chimeric G proteins could facilitate basic functional studies, drug screenings and deorphanization of other aGPCRs.
AB - Adhesion G protein-coupled receptors (aGPCRs) constitute the second largest subclass of the GPCR superfamily. Although canonical GPCRs are explored pharmacologically as drug targets, no clinically approved drugs target the aGPCR family so far. The aGPCR GPR56/ADGRG1 stands out as an especially promising target, given its direct link to the monogenetic disease bilateral frontoparietal polymicrogyria and implications in cancers. Key to understanding GPCR pharmacology has been mapping out intracellular signalling activity. Detection of GPCR signalling in the Gαs/Gαi/Gαq G protein pathways is feasible with second messenger detection systems. However, in the case of Gα12/13-coupled receptors, like GPR56, signalling detection is more challenging due to the lack of direct second messenger generation. To overcome this challenge, we engineered a Gαq chimera to translate Gα12/13 signalling. We show the ability of the chimeric GαΔ6q12myr and GαΔ6q13myr to translate basal Gα12/13 signalling of GPR56 to a Gαq readout in transcription factor luciferase reporter systems and show that the established peptide ligands (P7 and P19) function to enhance this signal. We further demonstrate the ability to directly influence the generation of second messengers in inositol-3-phosphate assays. In the future, these chimeric G proteins could facilitate basic functional studies, drug screenings and deorphanization of other aGPCRs.
KW - drug discovery and development
KW - G protein chimeras
KW - G protein-coupled 7TM receptors
KW - outcome measures
KW - Type II: adhesion GPCRs
U2 - 10.1111/bcpt.13935
DO - 10.1111/bcpt.13935
M3 - Journal article
C2 - 37621135
AN - SCOPUS:85171285188
VL - 133
SP - 378
EP - 389
JO - Basic and Clinical Pharmacology and Toxicology
JF - Basic and Clinical Pharmacology and Toxicology
SN - 1742-7835
IS - 4
ER -
ID: 367830475